Vanguard Group’s Arcturus Therapeutics ARCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $34.8M | Buy |
|
|||||
|
2025
Q2 | $23.6M | Buy |
|
|||||
|
2025
Q1 | $18.5M | Buy |
|
|||||
|
2024
Q4 | $28.6M | Buy |
|
|||||
|
2024
Q3 | $36.6M | Buy |
|
|||||
|
2024
Q2 | $33.7M | Sell |
|
|||||
|
2024
Q1 | $46.9M | Sell |
|
|||||
|
2023
Q4 | $46M | Buy |
|
|||||
|
2023
Q3 | $35.9M | Sell |
|
|||||
|
2023
Q2 | $46.7M | Buy |
|
|||||
|
2023
Q1 | $35.1M | Buy |
|
|||||
|
2022
Q4 | $24.6M | Buy |
|
|||||
|
2022
Q3 | $19.8M | Buy |
|
|||||
|
2022
Q2 | $18.8M | Buy |
|
|||||
|
2022
Q1 | $31.1M | Buy |
|
|||||
|
2021
Q4 | $42.5M | Buy |
|
|||||
|
2021
Q3 | $53.2M | Sell |
|
|||||
|
2021
Q2 | $39.9M | Sell |
|
|||||
|
2021
Q1 | $49.5M | Buy |
|
|||||
|
2020
Q4 | $51.3M | Buy |
|
|||||
|
2020
Q3 | $44.5M | Buy |
|
|||||
|
2020
Q2 | $40.7M | Buy |
|
|||||
|
2020
Q1 | $1.95M | Buy |
|
|||||
|
2019
Q4 | $1.35M | Hold |
|
|||||
|
2019
Q3 | $1.27M | Buy |
|